Key result
A 63-year-old male developed severe lower limb ischemia and multisystem dysfunction due to cholesterol embolization syndrome following CABG and IABP insertion, ultimately requiring bilateral below-knee amputation.
Why the study?
Cholesterol embolization syndrome is a complication of invasive procedures and endovascular therapies that is often overlooked and difficult to treat.
Case Report (n=1)
No
Cholesterol embolization syndrome is a severe and potentially limb-threatening complication of invasive cardiovascular procedures such as CABG and IABP.
Answers are grounded in this paper and cite their sources.
Raises awareness for cholesterol embolization syndrome after invasive cardiac procedures; leaves open optimal diagnostic and therapeutic approaches.
Following a Coronary artery bypass graft and insertion of an intra-aortic balloon pump, the 63 year-old male patient developed signs of progressive multi-organ dysfunction and ischaemic changes in both of his lower limbs. The diagnosis of cholesterol embolization syndrome was made. This condition has been noted to be a complication of invasive procedures and endovascular therapies, and is often overlooked and difficult to treat. While the patient’s renal function and pancreatitis showed improvement, the lower limb ischaemia was progressing. Eventually, the patient underwent a bilateral below knee amputation.
No takes yet. Share an insight, caveat, or question.
Faisal et al. (2021) conducted a case report in Cholesterol embolization syndrome (n=1). Coronary artery bypass grafting and intra-aortic balloon pump insertion was evaluated on Clinical outcome of cholesterol embolization syndrome. A 63-year-old male developed severe lower limb ischemia and multisystem dysfunction due to cholesterol embolization syndrome following CABG and IABP insertion, ultimately requiring bilateral below-knee amputation.
Synapse has enriched 10 related papers. Consider them for comparative context: